Dapagliflozin and Renal Surrogate Outcomes in Advanced Chronic Kidney Disease

Clinical trial NCT05196347 · COMPLETED

Trial details

NCT number: NCT05196347
Sponsor: Kaohsiung Medical University
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Kidney Diseases

Start date: 2022-05-27
Primary completion: 2024-08-31
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.